Get the Stockscreener App
1.75
5.42%
0.09
Pre-market:
1.76
0.01
+0.57%
Mangoceuticals Inc stock is traded at $1.75, with a volume of 171.65K.
It is up +5.42% in the last 24 hours and down -13.37% over the past month.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
See More
Previous Close:
$1.66
Open:
$1.75
24h Volume:
171.65K
Relative Volume:
0.65
Market Cap:
$17.35M
Revenue:
$755.00K
Net Income/Loss:
$-9.33M
P/E Ratio:
-0.3065
EPS:
-5.71
Net Cash Flow:
$-5.43M
1W Performance:
+10.76%
1M Performance:
-13.37%
6M Performance:
-41.47%
1Y Performance:
-70.98%
1-Day Range:
$1.66
$1.87
1-Week Range:
$1.5746
$2.08
52-Week Range:
$1.32
$7.659
Mangoceuticals Inc Stock (MGRX) Company Profile
Name
Mangoceuticals Inc
Sector
Industry
Phone
(833) 626-4679
Address
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
1.75 | 17.35M | 755.00K | -9.33M | -5.43M | -5.71 |
|
VEEV
Veeva Systems Inc
|
291.25 | 46.74B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
63.34 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
60.65 | 11.43B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.38 | 8.38B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.98 | 6.33B | 906.14M | -52.62M | 89.62M | -0.3621 |
Mangoceuticals Inc Stock (MGRX) Latest News
What drives Mangoceuticals Inc. stock priceOutstanding capital appreciation - Autocar Professional
Mangoceuticals Inc. Stock Analysis and ForecastTriple-digit returns - PrintWeekIndia
Can Mangoceuticals Inc. stock recover from recent declineExplosive capital appreciation - jammulinksnews.com
What analysts say about Mangoceuticals Inc. stock outlookExponentially increasing returns - jammulinksnews.com
What analysts say about Mangoceuticals Inc. stockSuperior portfolio returns - jammulinksnews.com
Is Mangoceuticals Inc. a good long term investmentExceptional earning trajectories - Autocar Professional
Mangoceuticals Amends Promissory Note with Tiger Cub Trust - TipRanks
Why Mangoceuticals Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser
MGRX’s Market Whiplash: -74.88% YTD Decline, -16.49% Plunge in 30 Days - investchronicle.com
What institutions are buying Mangoceuticals Inc. stock nowFree Consultation - Newser
Will Mangoceuticals Inc. stock split in the near futureHigh Yield Stock Selection - Newser
Mangoceuticals President Tony Isaac Resigns - MSN
What makes Mangoceuticals Inc. stock price move sharplyTrade Ready Signal - Newser
How Mangoceuticals Inc. stock performs during market volatilityFree Insider Trading Tips - Newser
Mangoceuticals (NASDAQ:MGRX) Stock Price Up 13% – Should You Buy? - Defense World
Mangoceuticals establishes 6% Series B convertible preferred stock By Investing.com - Investing.com Nigeria
Mangoceuticals establishes 6% Series B convertible preferred stock - Investing.com
Xeris Biopharma (NASDAQ:XERS) versus Mangoceuticals (NASDAQ:MGRX) Head to Head Review - Defense World
Mangoceuticals files to sell 4.46M shares of common stock by selling shareholders - MSN
Mangoceuticals president Tony Isaac resigns from board and executive role - Investing.com
MGRX SEC FilingsMangoceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Mangoceuticals (NASDAQ:MGRX) Trading Up 1.5% – Should You Buy? - Defense World
Mangoceuticals Inc Files For Mixed Shelf Of Up To $150 Million - MarketScreener
Mangoceuticals Inc Stock (MGRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
1.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):